Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
iGrow icon

1.0 by Pfizer Inc.


Dec 19, 2013

About iGrow

Enjoy millions of the latest Android apps, games, music, movies, TV, books, magazines & more. Anytime, anywhere, across your devices.

A new app from Pfizer lets you track your child’s proper development with a fun and innovative game! With a friendly interface and vocal instructions you can track your child’s height and weight, and see their percentile. The measurements are saved in the app so you track you child’s growth continually.

App features and benefits:

• Growth and weight calculator to track child proper development.

• Save all measurement results and easily send to doctor.

• Questions and answers section regarding your child proper development.

• Call our help line directly from the app.

*In case your child is suffering from GHD (Growth Hormone Deficiency), you can track his medication taking with a friendly interface that turns the injection into a fun star discovering game. The app saves a record of the injection time and points which can be easily sent to the doctor. The app also warns in case of improper use (e.g. more than one injection a day, etc.).

What's New in the Latest Version 1.0

Last updated on Dec 19, 2013

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Translation Loading...

Additional APP Information

Latest Version

Request iGrow Update 1.0

Requires Android

2.3.3 and up

Show More

iGrow Screenshots

Comment Loading...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.